104 related articles for article (PubMed ID: 8921413)
1. A 125 bp region of the Ig VH1 promoter is sufficient to confer lymphocyte-specific expression in transgenic mice.
Avitahl N; Calame K
Int Immunol; 1996 Sep; 8(9):1359-66. PubMed ID: 8921413
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the role of the 3'alpha heavy chain enhancer [3'alpha E(hs1,2)] in Vh gene somatic hypermutation.
Tumas-Brundage KM; Vora KA; Manser T
Mol Immunol; 1997 Apr; 34(5):367-78. PubMed ID: 9293770
[TBL] [Abstract][Full Text] [Related]
3. Mutations of the chloramphenicol acetyl transferase transgene driven by the immunoglobulin promoter and intron enhancer.
Azuma T; Motoyama N; Fields LE; Loh DY
Int Immunol; 1993 Feb; 5(2):121-30. PubMed ID: 8452812
[TBL] [Abstract][Full Text] [Related]
4. Hypermutation is observed only in antibody H chain V region transgenes that have recombined with endogenous immunoglobulin H DNA: implications for the location of cis-acting elements required for somatic mutation.
Giusti AM; Manser T
J Exp Med; 1993 Mar; 177(3):797-809. PubMed ID: 8436910
[TBL] [Abstract][Full Text] [Related]
5. Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription.
Shah PC; Bertolino E; Singh H
EMBO J; 1997 Dec; 16(23):7105-17. PubMed ID: 9384588
[TBL] [Abstract][Full Text] [Related]
6. The C/EBP family of transcriptional activators is functionally important for Ig VH promoter activity in vivo and in vitro.
Cooper C; Johnson D; Roman C; Avitahl N; Tucker P; Calame K
J Immunol; 1992 Nov; 149(10):3225-31. PubMed ID: 1431100
[TBL] [Abstract][Full Text] [Related]
7. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features.
Johnson TA; Rassenti LZ; Kipps TJ
J Immunol; 1997 Jan; 158(1):235-46. PubMed ID: 8977195
[TBL] [Abstract][Full Text] [Related]
8. Mapping the upstream boundary of somatic mutations in rearranged immunoglobulin transgenes and endogenous genes.
Rogerson BJ
Mol Immunol; 1994 Feb; 31(2):83-98. PubMed ID: 8309480
[TBL] [Abstract][Full Text] [Related]
9. Activation of immunoglobulin control elements in transgenic mice.
Miller AE; Ennist DL; Ozato K; Westphal H
Immunogenetics; 1992; 35(1):24-32. PubMed ID: 1729170
[TBL] [Abstract][Full Text] [Related]
10. The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL-4 via cooperative NF-kappa B and STAT-6 binding sites.
Schaffer A; Cerutti A; Shah S; Zan H; Casali P
J Immunol; 1999 May; 162(9):5327-36. PubMed ID: 10228008
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the imperfect octamer-containing human immunoglobulin VH6 gene promoter.
Sun Z; Kitchingman GR
Nucleic Acids Res; 1994 Mar; 22(5):850-60. PubMed ID: 8139927
[TBL] [Abstract][Full Text] [Related]
12. Selection of antigen-specific, idiotype-positive B cells in transgenic mice expressing a rearranged M167-mu heavy chain gene.
Kenny JJ; O'Connell C; Sieckmann DG; Fischer RT; Longo DL
J Exp Med; 1991 Nov; 174(5):1189-201. PubMed ID: 1940797
[TBL] [Abstract][Full Text] [Related]
13. The effects of E mu, 3'alpha (hs 1,2) and 3'kappa enhancers on mutation of an Ig-VDJ-Cgamma2a Ig heavy gene in cultured B cells.
Lin MM; Green NS; Zhang W; Scharff MD
Int Immunol; 1998 Aug; 10(8):1121-9. PubMed ID: 9723698
[TBL] [Abstract][Full Text] [Related]
14. The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially.
Rada C; Milstein C
EMBO J; 2001 Aug; 20(16):4570-6. PubMed ID: 11500383
[TBL] [Abstract][Full Text] [Related]
15. Somatic hypermutation of Ig genes is affected differently by failures in apoptosis caused by disruption of Fas (lpr mutation) or by overexpression of Bcl-2.
Mastache EF; Lindroth K; Fernández C; González-Fernández A
Scand J Immunol; 2006 Jun; 63(6):420-9. PubMed ID: 16764695
[TBL] [Abstract][Full Text] [Related]
16. Regulation of B cell development by variable gene complexity in mice reconstituted with human immunoglobulin yeast artificial chromosomes.
Green LL; Jakobovits A
J Exp Med; 1998 Aug; 188(3):483-95. PubMed ID: 9687526
[TBL] [Abstract][Full Text] [Related]
17. Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes.
Johnston JM; Ihyer SR; Smith RS; Tai KF; Farmer T; Korsmeyer SJ; Nadon NL; Carroll WL
Eur J Immunol; 1996 May; 26(5):1058-62. PubMed ID: 8647167
[TBL] [Abstract][Full Text] [Related]
18. Multiple sequences from downstream of the J kappa cluster can combine to recruit somatic hypermutation to a heterologous, upstream mutation domain.
Klix N; Jolly CJ; Davies SL; Brüggemann M; Williams GT; Neuberger MS
Eur J Immunol; 1998 Jan; 28(1):317-26. PubMed ID: 9485211
[TBL] [Abstract][Full Text] [Related]
19. Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggests that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human.
Küppers R; Hajadi M; Plank L; Rajewsky K; Hansmann ML
Eur J Immunol; 1996 Aug; 26(8):1794-800. PubMed ID: 8765023
[TBL] [Abstract][Full Text] [Related]
20. Promoter-associated displacement of hypermutations.
Wu P; Claflin L
Int Immunol; 1998 Aug; 10(8):1131-8. PubMed ID: 9723699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
